Earnings Call · Q3 FY2026·2026-10-29

Q3 26EPS n/a·Rev n/aQ2 26EPS -15.97%·Rev n/aQ1 26EPS +35.37%·Rev n/aQ4 25EPS -16.67%·Rev n/a⚠ consensus missing

ALNYLAM PHARMACEUTICALS, INC. ALNY

Conference Operator — Operator

Josh Brodsky — Vice President, Investor Relations

Yvonne Greenstreet — Chief Executive Officer

Tolga Tanguler — Chief Commercialization Officer

Pushkal Garg — Chief Research and Development Officer

Jeff Poulton — Chief Financial Officer

no move data

Research tier

Behavioral profile computed for 6 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ALNY calls or request research access.

More ALNY calls Browse calls Request research access